HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,613-6,624 of 27,277
Device study icon
CompletedNCT04103606

A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University Students

Official study title

A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Psychological Features in Female University Students: a Randomized Controlled Pilot Study with Crossover Design

This study has finished and is no longer accepting participants.

In Padua
Body dysmorphic disorder, Eating disordersDevice studyAges 18–30
Countries
Italy
Sponsor
University of Padova
Drug study icon
CompletedEUCTR 2007-001611-32

A multi-center cardiac safety study of subjects who participated in Organon sponsored Phase 1 and Phase 2 completed and discontinued trials with Org 24448 (Protocols: 22601;22602;22603; 153001;1530...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Netherlands
SchizophreniaHistorical research record
Countries
Netherlands
Sponsor
NV Organon
Drug study icon
CompletedEUCTR 2007-003035-22

A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
SchizophreniaHistorical research record
Countries
France, United Kingdom, Belgium, + 4 others
Sponsor
ACADIA Pharmaceuticals Inc.
Drug study icon
CompletedEUCTR 2011-002160-24

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients with Major D...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
DepressionHistorical research record
Countries
Austria, Germany, Slovakia
Sponsor
F. Hoffmann-La Roche Ltd.
Drug study icon
CompletedEUCTR 2018-003002-12

A multi-center, randomized, subject and investigator-blinded, placebo-controlled, active comparator, parallel-group proof of concept study to evaluate the efficacy, safety, tolerability, and pharma...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Spain
DepressionHistorical research record
Countries
Spain
Sponsor
Novartis Farmacéutica, S.A.
Drug study icon
CompletedEUCTR 2005-003745-14

A Multi-centre, Double-blind, Randomised Withdrawal, Parallel-group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Monothe...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Finland
DepressionHistorical research record
Countries
United Kingdom, Finland, Germany, + 1 other
Sponsor
AstraZeneca AB
Drug study icon
CompletedEUCTR 2006-001196-38

A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) as Mono-Therapy in t...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Estonia
DepressionHistorical research record
Countries
Estonia, Finland
Sponsor
AstraZeneca AB
Drug study icon
CompletedEUCTR 2005-005053-22

A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) in Combination with ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium, Czechia, Finland, + 2 others
Sponsor
AstraZeneca AB
Drug study icon
TerminatedEUCTR 2018-001166-42

A multi-centre, randomized, parallel-group, single blind Phase II trial to evaluate the pharmacokinetics and PKPD relationship of trazodone after single and repeated oral doses in children from 2 t...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Italy
ADHDHistorical research record
Countries
Italy, Spain
Sponsor
Aziende Chimiche Riunite Angelini Francesco ACRAF S.p.A (Angelini S.p.A.)
Other study type icon
CompletedACTRN12606000229572

A multi-component intervention for smoking cessation among Australian male prison inmates

Official study title

A randomised trial of nortriptyline, nicotine replacement therapy,and brief cognitive behavioural therapy (CBT) vs. placebo, nicotine replacement therapy, and brief cognitive behavioural therapy for smoking cessation among prison inmates.

This study has finished and is no longer accepting participants.

In Australia
AddictionInterventional studyAges 18+
Countries
Australia
Sponsor
University of New South Wales

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.